• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[德国老年人严重视力损害和失明的流行病学]

[Epidemiology of severe visual impairment and blindness of old people in Germany].

作者信息

Mauschitz M M, Li J Q, Larsen P P, Köberlein-Neu J, Holz F G, Breteler M M B, Finger R P

机构信息

Universitäts-Augenklinik, Universität Bonn, Ernst-Abbe-Str. 2, 53127, Bonn, Deutschland.

Populationsbezogene Gesundheitsforschung, Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE), Bonn, Deutschland.

出版信息

Ophthalmologe. 2019 Feb;116(2):201-212. doi: 10.1007/s00347-019-0853-y.

DOI:10.1007/s00347-019-0853-y
PMID:30715591
Abstract

Approximately 500,000 blind and 1 million visually impaired persons live in Germany, which lacks a national blind registry. Therefore data from social welfare agencies and population-based studies are used to estimate prevalence and incidence. Main causes for severe visual impairment and blindness are age-related macular degeneration, glaucoma and diabetic eye diseases. We observed a relative decline of the incidence of severe visual impairment and blindness over the last decades, which is primarily due to improved ophthalmic care and better treatment options. However, the absolute number of subjects with severe visual impairment and blindness increases due to population ageing. This will cause significant social and economic challenges in the future.

摘要

德国约有50万盲人以及100万视力受损者,但该国缺乏全国性的盲人登记系统。因此,社会福利机构的数据以及基于人群的研究被用于估算患病率和发病率。导致严重视力损害和失明的主要原因是年龄相关性黄斑变性、青光眼和糖尿病眼病。我们观察到,在过去几十年中,严重视力损害和失明的发病率相对下降,这主要归功于眼科护理的改善和更好的治疗选择。然而,由于人口老龄化,严重视力损害和失明患者的绝对数量有所增加。这将在未来引发重大的社会和经济挑战。

相似文献

1
[Epidemiology of severe visual impairment and blindness of old people in Germany].[德国老年人严重视力损害和失明的流行病学]
Ophthalmologe. 2019 Feb;116(2):201-212. doi: 10.1007/s00347-019-0853-y.
2
Prevalence and causes of registered blindness in the largest federal state of Germany.德国最大联邦州的登记致盲率及致盲原因。
Br J Ophthalmol. 2011 Aug;95(8):1061-7. doi: 10.1136/bjo.2010.194712. Epub 2011 Mar 3.
3
Causes of blindness and visual impairment in urban and rural areas in Beijing: the Beijing Eye Study.北京城乡地区失明和视力损伤的病因:北京眼病研究
Ophthalmology. 2006 Jul;113(7):1134.e1-11. doi: 10.1016/j.ophtha.2006.01.035. Epub 2006 May 2.
4
Visual impairment and blindness due to macular diseases globally: a systematic review and meta-analysis.全球因黄斑疾病导致的视力损害和失明:一项系统评价与荟萃分析。
Am J Ophthalmol. 2014 Oct;158(4):808-15. doi: 10.1016/j.ajo.2014.06.012. Epub 2014 Jun 25.
5
Prevalence and causes of visual impairment in an elderly Chinese population in Taiwan: the Shihpai Eye Study.台湾石牌地区老年人群视力损害的患病率及原因:石牌眼科研究
Ophthalmology. 2004 Jan;111(1):62-9. doi: 10.1016/j.ophtha.2003.05.011.
6
Global Estimates on the Number of People Blind or Visually Impaired by Diabetic Retinopathy: A Meta-analysis From 1990 to 2010.全球因糖尿病视网膜病变致盲或视力受损人数的估计:1990 年至 2010 年的荟萃分析。
Diabetes Care. 2016 Sep;39(9):1643-9. doi: 10.2337/dc15-2171.
7
Causes of blindness and visual impairment in Pakistan. The Pakistan national blindness and visual impairment survey.巴基斯坦失明和视力损害的原因。巴基斯坦全国失明和视力损害调查。
Br J Ophthalmol. 2007 Aug;91(8):1005-10. doi: 10.1136/bjo.2006.108035. Epub 2007 Jan 17.
8
[Blindness in Germany--today and in 2030].[德国的失明情况——现状与2030年展望]
Ophthalmologe. 2006 Sep;103(9):735-41. doi: 10.1007/s00347-006-1411-y.
9
Factors associated with vision-related quality of life among the adult population living in Nagorno Karabagh.居住在纳戈尔诺-卡拉巴赫的成年人口中与视力相关生活质量相关的因素。
Public Health. 2017 Dec;153:137-146. doi: 10.1016/j.puhe.2017.09.004. Epub 2017 Oct 16.
10
Causes of Permanent Severe Visual Impairment and Blindness among Jordanian Population.约旦人群永久性严重视力损害和失明的原因。
Middle East Afr J Ophthalmol. 2018 Jan-Mar;25(1):25-29. doi: 10.4103/meajo.MEAJO_202_16.

引用本文的文献

1
[Digital remote monitoring of chronic retinal conditions-A clinical future tool? : Remote monitoring of chronic retinal conditions].[慢性视网膜疾病的数字远程监测——一种临床未来工具?:慢性视网膜疾病的远程监测]
Ophthalmologie. 2024 Oct;121(10):826-834. doi: 10.1007/s00347-024-02109-2. Epub 2024 Sep 14.
2
Decline in Blindness in Persons Up to Age 65 and the Associated Lost Years of Gainful Employment.65岁及以下人群失明率的下降以及相关的有酬就业损失年数。
Dtsch Arztebl Int. 2024 Mar 22;121(6):198-199. doi: 10.3238/arztebl.m2023.0271.
3
Epidemiology of Diagnosed Age-related Macular Degeneration in Germany: An Evaluation of the Prevalence Using AOK PLUS Claims Data.

本文引用的文献

1
Visual impairment and blindness in institutionalized elderly in Germany.德国机构养老老年人的视力损害与失明情况。
Graefes Arch Clin Exp Ophthalmol. 2019 Feb;257(2):363-370. doi: 10.1007/s00417-018-4196-1. Epub 2018 Nov 27.
2
Global causes of blindness and distance vision impairment 1990-2020: a systematic review and meta-analysis.全球失明和远距离视力损伤原因 1990-2020:系统回顾和荟萃分析。
Lancet Glob Health. 2017 Dec;5(12):e1221-e1234. doi: 10.1016/S2214-109X(17)30393-5. Epub 2017 Oct 11.
3
[Ophthalmological health care of the institutionalized elderly : The OVIS study].
德国确诊年龄相关性黄斑变性的流行病学:使用AOK PLUS索赔数据对患病率的评估
Ophthalmol Ther. 2024 Apr;13(4):1025-1039. doi: 10.1007/s40123-024-00901-6. Epub 2024 Feb 22.
4
[Global ophthalmology : Update].[全球眼科:最新进展]
Ophthalmologie. 2024 Feb;121(2):157-170. doi: 10.1007/s00347-023-01983-6. Epub 2024 Feb 1.
5
Cross-sectional study investigating the prevalence and causes of vision impairment in Northwest Portugal using capture-recapture.使用捕获-再捕获法调查葡萄牙西北部视力障碍的患病率和原因的横断面研究。
BMJ Open. 2022 Sep 8;12(9):e056995. doi: 10.1136/bmjopen-2021-056995.
6
Progression to severe visual impairment and blindness in POAG patients: pace and risk factors-a cohort study using German health claims data.POAG 患者视力严重受损和失明的进展:速度和风险因素——使用德国健康索赔数据的队列研究。
BMJ Open Ophthalmol. 2022 Jan 31;7(1):e000838. doi: 10.1136/bmjophth-2021-000838. eCollection 2022.
7
Anti-VEGF therapies for age-related macular degeneration: a powerful tactical gear or a blunt weapon? The choice is ours.抗血管内皮生长因子治疗年龄相关性黄斑变性:强有力的战术装备还是钝器?选择权在我们手中。
Graefes Arch Clin Exp Ophthalmol. 2021 Dec;259(12):3561-3567. doi: 10.1007/s00417-021-05451-2. Epub 2021 Oct 20.
8
The Diagnosis and Treatment of Age-Related Macular Degeneration.年龄相关性黄斑变性的诊断与治疗。
Dtsch Arztebl Int. 2020 Jul 20;117(29-30):513-520. doi: 10.3238/arztebl.2020.0513.
9
Markedly decreasing incidence of cause-specific blindness in Saxony (Eastern Germany).萨克森州(德国东部)特定病因致盲发病率显著下降。
Graefes Arch Clin Exp Ophthalmol. 2021 May;259(5):1089-1101. doi: 10.1007/s00417-020-04885-4. Epub 2020 Sep 25.
10
[Ophthalmology 2019-where do we stand? : An analysis of the treatment situation in Germany].[2019年眼科领域现状:德国治疗情况分析]
Ophthalmologe. 2019 Sep;116(9):829-837. doi: 10.1007/s00347-019-0894-2.
[机构养老老年人的眼科保健:OVIS研究]
Ophthalmologe. 2017 Sep;114(9):818-827. doi: 10.1007/s00347-017-0557-0.
4
Prevalence of Age-Related Macular Degeneration in Europe: The Past and the Future.欧洲年龄相关性黄斑变性的患病率:过去与未来
Ophthalmology. 2017 Dec;124(12):1753-1763. doi: 10.1016/j.ophtha.2017.05.035. Epub 2017 Jul 14.
5
The Economic Impact of Blindness in Europe.欧洲失明问题的经济影响。
Ophthalmic Epidemiol. 2017 Aug;24(4):239-247. doi: 10.1080/09286586.2017.1281426. Epub 2017 Jun 30.
6
Equity and Blindness: Closing Evidence Gaps to Support Universal Eye Health.公平与失明:弥合证据差距以支持全球眼健康
Ophthalmic Epidemiol. 2015;22(5):297-307. doi: 10.3109/09286586.2015.1077977.
7
[Demography and age-dependency in ophthalmic diseases].[眼科疾病中的人口统计学与年龄依赖性]
Ophthalmologe. 2015 Jan;112(1):73-80; quiz 81. doi: 10.1007/s00347-014-3182-1.
8
The economic burden of visual impairment and blindness: a systematic review.视力障碍和失明的经济负担:系统评价。
BMJ Open. 2013 Nov 7;3(11):e003471. doi: 10.1136/bmjopen-2013-003471.
9
Blindness and visual impairment in Germany: a slight fall in prevalence.德国的盲和视力损伤:患病率略有下降。
Dtsch Arztebl Int. 2012 Jul;109(27-28):484-9. doi: 10.3238/arztebl.2012.0484. Epub 2012 Jul 9.
10
Evidence for a considerable decrease in total and cause-specific incidences of blindness in Germany.德国全因及特定病因失明发病率显著下降的证据。
Eur J Epidemiol. 2012 Jul;27(7):519-24. doi: 10.1007/s10654-012-9705-7. Epub 2012 Jun 19.